Moderna shares fall after Rothschild & Co Redburn downgrade to Sell
Moderna shares fell 2.9% in the afternoon session after Rothschild & Co Redburn analyst Simon Baker downgraded the company to Sell from Neutral on valuation concerns.
What Happened? Shares of biotechnology company Moderna NASDAQ:MRNAfell 2.9% in the afternoon session after Rothschild & Co Redburn analyst Simon Baker downgraded the company to Sell from Neutral on valuation concerns.
Baker raised Moderna's price target to $81 from $40, representing a 46% downside…